Included In This Lesson
Outline
What is the Generic Name
BRIGATINIB
What is the Trade Name for BRIGATINIB
Alunbrig
What is the Indication for BRIGATINIB
- 1 INDICATIONS AND USAGE ALUNBRIG is indicated for the treatment of adult patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) as detected by an FDA-approved test [see Dosage and Administration (2.1) ] . ALUNBRIG is a kinase inhibitor indicated for the treatment of adult patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) as detected by an FDA-approved test. ( 1 , 2.1 )
View Our Nursing Pharmacology Course
References: https://open.fda.gov/
Other Pharm Resources